Randomized Phase III Trial of Sorafenib Versus Placebo in Asian Patients with Advanced Hepatocellular Carcinoma

Reviewer: Eric Shinohara MD, MSCI
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 2 de junio del 2008

Translation for this article does not exist


Catherine and Finn
by OncoLink Editorial Team
December 01, 2015